Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sustained-release Dexamphetamine in Cocaine Use Disorder With Comorbid Opioid Use Disorder
NCT05529927Phase 2Recruiting
- Sponsor
- Parnassia Addiction Research Centre
- Start
- Apr 2026
- Primary completion
- Jan 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dextroamphetamine in cocaine use disorder (CUD), sponsored by Parnassia Addiction Research Centre. Started Apr 2026; status: recruiting.
02
Drugs
dextroamphetamine
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT05529927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05529927.